Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
01/2002
01/03/2002DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin
01/03/2002CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use
01/03/2002CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents
01/02/2002EP1167373A1 Ferrocenyldiphosphine-ruthenium complexes and a hydrogenation process of exocyclic double bond of d-thiophene to d-thiophane
01/02/2002EP1167368A1 Process for the preparation of 3,4-alkylenedioxythiophene-2,5-dicarboxylic acid derivatives
01/02/2002EP1167367A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
01/02/2002EP1166785A1 Use of pyrazole derivatives for inhibiting thrombin-induced platelet aggregation
01/02/2002EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
01/02/2002EP1165555A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
01/02/2002EP1165545A1 Novel compounds
01/02/2002EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
01/02/2002EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
01/02/2002EP1021449B1 Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
01/02/2002EP0785938B1 Fused pyrrolocarbazoles
01/01/2002US6335358 Lactacystin analogs
12/2001
12/27/2001WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/27/2001CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/26/2001CN1328561A Pyrimidin-4-enamine as fungicide
12/26/2001CN1328461A Method for preventing/treating damage to sensory hair cells and cochlear neurons
12/25/2001US6333417 Contacting substituted biotin with sulfuric acid having concentration of 90% by weight or more in presence of aromatic hydrocarbon
12/20/2001WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
12/20/2001WO2001095911A1 Protease inhibitors
12/20/2001WO2001095857A2 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates
12/20/2001WO2001064192A3 Use of benzothieno-2,3-d-pyrimidines with pde v inhibitory effect for the treatment of erectile dysfunction
12/20/2001DE10029078A1 Decarboxylation of 3,4-alkylenedioxythiophene dicarboxylic acids to 3,4-alkylenedioxythiophenes in an amine solvent to avoid the use of copper catalysts
12/20/2001DE10029075A1 Two- or three-stage preparation of high-purity 3,4-alkylenedioxythiophene-2,5-dicarboxylic derivatives or acids is effected without isolation of the intermediates
12/20/2001CA2412632A1 Hmg-coa reductase inhibitors and method
12/20/2001CA2412353A1 Protease inhibitors
12/19/2001EP1164121A1 Novel carboxylic acid derivatives and process for producing the same
12/19/2001EP1163244A1 Thienopyrimidine compounds, their production and use
12/19/2001EP1163240A1 Tricyclic benzoylpyrazole derivatives used as a herbicide
12/18/2001US6331640 Diaminopropionic acid derivatives
12/13/2001WO2001094353A1 Thiophene derivatives useful as anticancer agents
12/13/2001WO2001025241A3 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
12/13/2001US20010051722 Aminoaryl Oxazolidinone N-oxides
12/13/2001US20010051620 Tricyclic protein kinase inhibitors
12/13/2001CA2411084A1 Thiophene derivatives useful as anticancer agents
12/12/2001EP1162196A1 Fused-ring compounds and use thereof as drugs
12/12/2001EP1161555A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system
12/12/2001EP0670751B1 Improved sensor membranes
12/12/2001EP0646019B1 Biotin-DOTA conjugates and their use in pretargeting methods
12/12/2001CN1326114A Image element containing closed compounds for taking pictures
12/11/2001US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001US6329388 Thienopyridine compounds, their production and use
12/11/2001US6329387 Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
12/11/2001US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001US6329369 Methods of treating pain and other conditions
12/06/2001WO2001092267A2 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001WO2001010847A8 Novel integrin receptor antagonists
12/06/2001CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx
12/05/2001EP1159279A2 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
12/05/2001EP1158986A1 Protease inhibitors
12/05/2001CN1075799C Monomers and composition which can be crosslinked and crosslinked polymers
11/2001
11/29/2001WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001WO2001089521A1 Medicinal compositions containing thiophene derivatives
11/29/2001WO2001089451A2 Protease inhibitors
11/29/2001US20010047008 Allosteric adenosine receptor modulators
11/29/2001US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
11/29/2001DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001CA2406829A1 Protease inhibitors
11/28/2001EP1158358A2 Imaging element containing a blocked photographically useful compound
11/28/2001EP1157027A1 Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
11/28/2001EP1156808A2 Enhancement of return to independent living status with a growth hormone secretagogue
11/27/2001US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001US6323217 Cardiovascular disorders
11/27/2001US6323215 Treat and prevent disorders characterized by neuronal damage such as parkinson's disease, alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and bell's palsy.
11/27/2001US6323214 Allosteric adenosine receptor modulators
11/27/2001US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/22/2001WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001WO2001087830A2 Substituted thioacetamides
11/22/2001WO2001087038A2 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
11/22/2001WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/22/2001US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001US20010044445 Azole inhibitors of cytokine production
11/22/2001CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001CA2409116A1 Substituted thioacetamides
11/21/2001EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases
11/21/2001EP1154997A1 Pharmaceutically active compounds and methods of use thereof
11/21/2001EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001CN1323307A 1H-imidazopyridine derivatives
11/21/2001CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides
11/21/2001CN1074926C Antiarrhythmic benzodiazepines
11/20/2001CA2046126C 2-thienylglycidic derivative, process for its preparation and its use as synthesis intermediate
11/15/2001WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/15/2001CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor